nad has been researched along with a-Synucleinopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Facey, PD; Hirth, F; Kocinaj, A; Parsons, AE; Parsons, RB; Prendergast, SA; Ruiz Pulido, G | 1 |
1 other study(ies) available for nad and a-Synucleinopathies
Article | Year |
---|---|
Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
Topics: alpha-Synuclein; Dopaminergic Neurons; Humans; NAD; Neurites; Neuroblastoma; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Synucleinopathies | 2022 |